Search Videos and More

Showing 25 - 29 of 29 results

Previous| 1 | 2 | 3 |Next


Surgical Systemic Vein Turndown For Thoracic Duct Decompression in Fontan Patients With Protein-Losing Enteropathy: Role of Multimodality Imaging News

Surgical Systemic Vein Turndown For Thoracic Duct Decompression in Fontan Patients With Protein-Losing Enteropathy: Role of Multimodality Imaging

A recent American College of Cardiology expert analysis reviews surgical systemic vein (innominate vein) turndown as a promising treatment for protein?losing enteropathy (PLE) in patients with Fontan circulation.
An Update of Invasive Implanted Hemodynamic Monitoring in Patients With Fontan Circulation News

An Update of Invasive Implanted Hemodynamic Monitoring in Patients With Fontan Circulation

What are the safety, utility, and prognostic implications of invasive implanted hemodynamic monitoring (IHM) using the CardioMEMS™ HF System (Abbott Laboratories, Abbott Park, Illinois) in patients with Fontan circulation (FC)?
Case report: Additional Imaging Supports TAPVR Care News

Case report: Additional Imaging Supports TAPVR Care

A case report shows that advanced cardiac CT and MRI imaging can improve surgical planning and reintervention for patients with infradiaphragmatic total anomalous pulmonary venous return (TAPVR). See what Sebastián Quiñones-Carrasquillo, MD, and co-authors Todd Nowlen, MD and Daniel Velez, MD, recommend for using these advanced diagnostic imaging modalities.
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation News

Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation

The impact of Fontan-associated liver disease (FALD) on post-transplant mortality and indications for combined heart-liver transplant (CHLT) in adult Fontan patients remains unknown.
Risk Stratification for Subclinical Pediatric Dyslipidemia Video

Risk Stratification for Subclinical Pediatric Dyslipidemia

Cholesterol continues to be challenging to manage in the pediatric population. When should pediatricians institute cholesterol-lowering medications? Dr. Damon Dixon reviews tools that can aid in this decision.

Showing 25 - 29 of 29 results

Previous| 1 | 2 | 3 |Next